Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.52−0.09 (-5.30%)
Close on Nov 17, 2026Market cap $24.93MP/E –Yield –
Cellyan Biotechnology r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Cellyan Biotechnology
Cellyan Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?